{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:06:46Z","timestamp":1775714806671,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T00:00:00Z","timestamp":1161129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,11,21]]},"DOI":"10.1007\/s00213-006-0576-z","type":"journal-article","created":{"date-parts":[[2006,10,17]],"date-time":"2006-10-17T18:56:34Z","timestamp":1161111394000},"page":"565-573","source":"Crossref","is-referenced-by-count":89,"title":["The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans"],"prefix":"10.1007","volume":"189","author":[{"given":"Manuel","family":"Tancer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris-Ellyn","family":"Johanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,10,18]]},"reference":[{"key":"576_CR1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0091-3057(96)00334-6","volume":"57","author":"LE Baker","year":"1997","unstructured":"Baker LE, Taylor MM (1997) Assessment of the MDA and MDMA optical isomers in a stimulant-hallucinogen discrimination. Pharmacol Biochem Behav 57:737\u2013748","journal-title":"Pharmacol Biochem Behav"},{"key":"576_CR2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00008877-199504000-00007","volume":"6","author":"LE Baker","year":"1995","unstructured":"Baker LE, Broadbent J, Michael EK, Matthews PK, Metosh CA, Saunders RB, West WB, Appel JB (1995) Assessment of the discriminative stimulus effects of the optical isomers of ecstasy (3,4-methylenedioxymethamphetamine; MDMA). Behav Pharmacol 6:263\u2013275","journal-title":"Behav Pharmacol"},{"key":"576_CR3","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.npp.1300585","volume":"30","author":"MH Baumann","year":"2005","unstructured":"Baumann MH, Clark RD, Budzynski AG, Partilla JS, Blough BE, Rothman RB (2005) N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or \u2018Ecstasy\u2019). Neuropsychopharmacology 30:550\u2013560","journal-title":"Neuropsychopharmacology"},{"key":"576_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(92)90023-W","volume":"215","author":"UV Berger","year":"1992","unstructured":"Berger UV, Gu XF, Azmitia EC (1992) The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. Eur J Pharmacol 215:153\u2013160","journal-title":"Eur J Pharmacol"},{"key":"576_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-3223(95)00110-7","volume":"39","author":"LH Brauer","year":"1996","unstructured":"Brauer LH, de Wit H (1996) Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry 39:26\u201332","journal-title":"Biol Psychiatry"},{"key":"576_CR6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0091-3057(96)00240-7","volume":"56","author":"LH Brauer","year":"1997","unstructured":"Brauer LH, de Wit H (1997) High dose pimozide does not block amphetamine-induced euphoria in normal volunteers. Pharmacol Biochem Behav 56:265\u2013272","journal-title":"Pharmacol Biochem Behav"},{"key":"576_CR7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002130050207","volume":"130","author":"LH Brauer","year":"1997","unstructured":"Brauer LH, Goudie AJ, de Wit H (1997) Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology (Berl) 130:2\u201313","journal-title":"Psychopharmacology (Berl)"},{"key":"576_CR8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00004714-200008000-00010","volume":"20","author":"J Cami","year":"2000","unstructured":"Cami J, Farre M, Mas M, Roset PN, Poudevida S, Mas A, San L, de la Torre R (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d): psychomotor performance and subjective effects. J Clin Psychopharmacol 20:455\u2013466","journal-title":"J Clin Psychopharmacol"},{"key":"576_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0163-7258(03)00003-2","volume":"98","author":"JC Cole","year":"2003","unstructured":"Cole JC, Sumnall HR (2003a) Altered states: the clinical effects of ecstasy. Pharmacol Ther 98:35\u201358","journal-title":"Pharmacol Ther"},{"key":"576_CR10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0149-7634(03)00031-9","volume":"27","author":"JC Cole","year":"2003","unstructured":"Cole JC, Sumnall HR (2003b) The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev 27:199\u2013217","journal-title":"Neurosci Biobehav Rev"},{"key":"576_CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0376-8716(86)90048-7","volume":"18","author":"SM Evans","year":"1986","unstructured":"Evans SM, Johanson CE (1986) Discriminative stimulus properties of (\u00b1)-3,4-methylenedioxymethamphetamine and (\u00b1)-3,4-methylenedioxyamphetamine in pigeons. Drug Alcohol Depend 18:159\u2013164","journal-title":"Drug Alcohol Depend"},{"key":"576_CR12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00213-002-1021-6","volume":"161","author":"WE Fantegrossi","year":"2002","unstructured":"Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G (2002) 3,4-Methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d) and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement. Psychopharmacology (Berl) 161:356\u2013364","journal-title":"Psychopharmacology (Berl)"},{"key":"576_CR13","doi-asserted-by":"crossref","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1996) Structured clinical interview of DSM-IV axis I disorders\u2014patient edition (SCID I\/P, Version 2). Biometrics Research Department, NY State Psychiatric Institute, New York","DOI":"10.1037\/t07827-000"},{"key":"576_CR14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0091-3057(88)90001-9","volume":"29","author":"RA Glennon","year":"1988","unstructured":"Glennon RA, Yousif M, Patrick G (1988) Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol Biochem Behav 29:443\u2013449","journal-title":"Pharmacol Biochem Behav"},{"key":"576_CR15","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1037\/1064-1297.8.3.415","volume":"8","author":"AK Goodwin","year":"2000","unstructured":"Goodwin AK, Baker LE (2000) A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (\u00b1)-MDMA in rats. Exp Clin Psychopharmacol 8:415\u2013423","journal-title":"Exp Clin Psychopharmacol"},{"key":"576_CR16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0091-3057(03)00029-7","volume":"74","author":"AK Goodwin","year":"2003","unstructured":"Goodwin AK, Pynnonen DM, Baker LE (2003) Serotonergic-dopaminergic mediation of MDMA\u2019s discriminative stimulus effects in a three-choice discrimination. Pharmacol Biochem Behav 74:987\u2013995","journal-title":"Pharmacol Biochem Behav"},{"key":"576_CR17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/pr.55.3.3","volume":"55","author":"AR Green","year":"2003","unstructured":"Green AR, Mechan AO, Elliott JM, O\u2019Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, \u201cecstasy\u201d). Pharmacol Rev 55:463\u2013508","journal-title":"Pharmacol Rev"},{"key":"576_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199302000-00001","volume":"4","author":"RR Griffiths","year":"1993","unstructured":"Griffiths RR, Troisi JR, Silverman K, Mumford GK (1993) Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 4:3\u201313","journal-title":"Behav Pharmacol"},{"key":"576_CR19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00213-002-1131-1","volume":"162","author":"DS Harris","year":"2002","unstructured":"Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT (2002) Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 162:396\u2013405","journal-title":"Psychopharmacology (Berl)"},{"key":"576_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0014-2999(90)90555-K","volume":"177","author":"CR Hekmatpanah","year":"1990","unstructured":"Hekmatpanah CR, Peroutka SJ (1990) 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents. Eur J Pharmacol 177:95\u201398","journal-title":"Eur J Pharmacol"},{"key":"576_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugalcdep.2005.05.003","volume":"81","author":"C-E Johanson","year":"2006","unstructured":"Johanson C-E, Kilbey M, Gatchalian K, Tancer M (2006) Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, metachlorophenylpiperazine and placebo. Drug Alcohol Depend 81:27\u201336","journal-title":"Drug Alcohol Depend"},{"key":"576_CR22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0376-8716(86)90046-3","volume":"18","author":"JB Kamien","year":"1986","unstructured":"Kamien JB, Johanson CE, Schuster CR, Woolverton WL (1986) The effects of (\u00b1)-methylenedioxymethamphetamine and (\u00b1)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline. Drug Alcohol Depend 18:139\u2013147","journal-title":"Drug Alcohol Depend"},{"key":"576_CR23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF01273176","volume":"104","author":"S Koch","year":"1997","unstructured":"Koch S, Galloway MP (1997) MDMA induced dopamine release in vivo: role of endogenous serotonin. J Neural Transm 104:135\u2013146","journal-title":"J Neural Transm"},{"key":"576_CR24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0924-977X(00)00086-9","volume":"10","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Vollenweider FX (2000a) Acute psychological and physiological effects of MDMA (\u201cEcstasy\u201d) after haloperidol pretreatment in healthy humans. Eur Neuropsychopharmacol 10:289\u2013295","journal-title":"Eur Neuropsychopharmacol"},{"key":"576_CR25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/026988110001400313","volume":"14","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Vollenweider FX (2000b) The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine (\u2018Ecstasy\u2019) in healthy volunteers. J Psychopharmacol 14:269\u2013274","journal-title":"J Psychopharmacol"},{"key":"576_CR26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0893-133X(99)00148-7","volume":"22","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Baumann C, Gamma A, Vollenweider FX (2000a) Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) are attenuated by the serotonin uptake inhibitor citalopram. Neuropsychopharmacology 22:513\u2013521","journal-title":"Neuropsychopharmacology"},{"key":"576_CR27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0893-133X(00)00126-3","volume":"23","author":"ME Liechti","year":"2000","unstructured":"Liechti ME, Saur MR, Gamma A, Hell D, Vollenweider FX (2000b) Psychological and physiological effects of MDMA (\u201cEcstasy\u201d) after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans. Neuropsychopharmacology 23:396\u2013404","journal-title":"Neuropsychopharmacology"},{"key":"576_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, ephedrine, phemetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245\u2013258","journal-title":"Clin Pharmacol Ther"},{"key":"576_CR29","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/00004714-199306000-00011","volume":"13","author":"UD McCann","year":"1993","unstructured":"McCann UD, Ricaurte GA (1993) Reinforcing subjective effects of (\u00b1) 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d) may be separable from its neurotoxic actions: clinical evidence. J Clin Psychopharmacol 13:214\u2013217","journal-title":"J Clin Psychopharmacol"},{"key":"576_CR30","volume-title":"Manual for the profile of mood states","author":"DM McNair","year":"1971","unstructured":"McNair DM, Lorr M, Droppleman LF (1971) Manual for the profile of mood states. Educational and Industrial Testing Service, San Diego, CA"},{"key":"576_CR31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.bjp.0704442","volume":"135","author":"AO Mechan","year":"2002","unstructured":"Mechan AO, Esteban B, O\u2019Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, \u2018ecstasy\u2019) to rats. Br J Pharmacol 135:170\u2013180","journal-title":"Br J Pharmacol"},{"key":"576_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF00212770","volume":"95","author":"R Oberlender","year":"1988","unstructured":"Oberlender R, Nichols DE (1988) Drug discrimination studies with MDMA and amphetamine. Psychopharmacology 95:71\u201376","journal-title":"Psychopharmacology"},{"key":"576_CR33","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1073\/pnas.89.5.1817","volume":"89","author":"G Rudnick","year":"1992","unstructured":"Rudnick G, Wall SC (1992) The molecular mechanism of \u201cecstasy\u201d [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci USA 89:1817\u20131821","journal-title":"Proc Natl Acad Sci USA"},{"key":"576_CR34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/0091-3057(86)90480-6","volume":"24","author":"MD Schechter","year":"1986","unstructured":"Schechter MD (1986) Discriminative profile of MDMA. Pharmacol Biochem Behav 24:1533\u20131537","journal-title":"Pharmacol Biochem Behav"},{"key":"576_CR35","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(90)90254-4","volume":"181","author":"CJ Schmidt","year":"1990","unstructured":"Schmidt CJ, Taylor VL (1990) Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors. Eur J Pharmacol 181:133\u2013136","journal-title":"Eur J Pharmacol"},{"key":"576_CR36","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0006-2952(87)90729-5","volume":"36","author":"CJ Schmidt","year":"1987","unstructured":"Schmidt CJ, Levin JA, Lovenberg W (1987) In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem Pharmacol 36:747\u2013755","journal-title":"Biochem Pharmacol"},{"key":"576_CR37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner RK (1994) Dose response study of NN-dimethyltryptamine in humans. Arch Gen Psychiatry 51:98\u2013108","journal-title":"Arch Gen Psychiatry"},{"key":"576_CR38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0376-8716(01)00146-6","volume":"65","author":"ME Tancer","year":"2001","unstructured":"Tancer ME, Johanson CE (2001) The subjective effects of MDMA and mCPP in moderate MDMA users. Drug Alcohol Depend 65:97\u2013101","journal-title":"Drug Alcohol Depend"},{"key":"576_CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0376-8716(03)00172-8","volume":"72","author":"M Tancer","year":"2003","unstructured":"Tancer M, Johanson CE (2003) Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug Alcohol Depend 72:33\u201344","journal-title":"Drug Alcohol Depend"},{"key":"576_CR40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.npp.1395197","volume":"19","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider FX, Gamma A, Liechti M, Huber T (1998) Psychological and cardiovascular effects and short-term sequelae of MDMA (\u201cecstasy\u201d) in MDMA-naive healthy volunteers. Neuropsychopharmacology 19:241\u2013251","journal-title":"Neuropsychopharmacology"},{"key":"576_CR41","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0301-0082(96)00027-5","volume":"49","author":"SR White","year":"1996","unstructured":"White SR, Obradovic T, Imel KM, Wheaton MJ (1996) The effects of methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 49:455\u2013479","journal-title":"Prog Neurobiol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0576-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-006-0576-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0576-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:29Z","timestamp":1558629089000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-006-0576-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,18]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11,21]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1007\/s00213-006-0576-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,18]]}}}